Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Net Income - Minority came in at $333512.0 in Q1 2026, down 0.77% quarter-over-quarter from $336100.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Net Income - Minority across 15 years of filings, most recently posting $333512.0 for Q1 2026.
- Net Income - Minority for Q1 2026 came in at $333512.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $333512.0 (changed N/A YoY), and the FY2025 annual result was $336100.0, up 9.29% from the prior year.
- Net Income - Minority came in at $333512.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $336100.0 in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of $336100.0 in Q4 2025 to a low of $307517.0 in Q4 2024.
- The 3-year median for Net Income - Minority is $333512.0 (2026), against an average of $325709.7.
- Peak annual rise in Net Income - Minority reached 9.29% in 2025, while the deepest fall reached 9.29% in 2025.
- Cumberland Pharmaceuticals' Net Income - Minority stood at $307517.0 in 2024, then increased by 9.29% to $336100.0 in 2025, then decreased by 0.77% to $333512.0 in 2026.
- The last three Net Income - Minority figures came in at $333512.0 (Q1 2026), $336100.0 (Q4 2025), and $307517.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -4.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Cumberland Pharmaceuticals | 86.62 Mn | 75.28 Mn | 7.20 Mn | 333,512.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333,512.00 |
| Dec 31, 2025 | 336,100.00 |
| Dec 31, 2024 | 307,517.00 |
| Jun 30, 2021 | 144,352.00 |
| Mar 31, 2021 | 139,283.00 |
| Dec 31, 2020 | 117,116.00 |
| Sep 30, 2020 | 85,426.00 |
| Jun 30, 2020 | 69,459.00 |
| Mar 31, 2020 | 47,145.00 |
| Dec 31, 2019 | 37,620.00 |
| Sep 30, 2019 | 25,980.00 |
| Jun 30, 2019 | 372,306.00 |
| Mar 31, 2019 | 240,806.00 |
| Dec 31, 2018 | 274,266.00 |
| Sep 30, 2018 | 257,251.00 |
| Jun 30, 2018 | 236,274.00 |
| Mar 31, 2018 | 211,512.00 |
| Dec 31, 2017 | 198,562.00 |
| Sep 30, 2017 | 177,303.00 |
| Jun 30, 2017 | 163,094.00 |